Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations
- 1 September 2004
- journal article
- Published by Elsevier in Toxicology
- Vol. 201 (1-3) , 67-75
- https://doi.org/10.1016/j.tox.2004.04.019
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1Nature, 2004
- Sphingolipids and the regulation of the immune responseSeminars in Immunology, 2002
- Fumonisin-Induced Tumor Necrosis Factor-α Expression in a Porcine Kidney Cell Line Is Independent of Sphingoid Base Accumulation Induced by Ceramide Synthase InhibitionToxicology and Applied Pharmacology, 2001
- Sphingolipid Metabolism: Roles in Signal Transduction and Disruption by FumonisinsEnvironmental Health Perspectives, 2001
- The FTY720 StoryTherapeutic Drug Monitoring, 2000
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Dual Roles of Sphingolipids in Signaling of the Escape from and Onset of Apoptosis in a Mouse Cytotoxic T-cell Line, CTLL-2Journal of Biological Chemistry, 1996
- Serine Palmitoyltransferase Is the Primary Target of a Sphingosine-like Immunosuppressant, ISP-1/MyriocinBiochemical and Biophysical Research Communications, 1995
- Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activityBioorganic & Medicinal Chemistry Letters, 1995
- Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite.The Journal of Antibiotics, 1994